Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tevogen Bio Holdings

0.9796
-0.0404-3.96%
Post-market: 0.98000.0004+0.04%19:58 EDT
Volume:536.91K
Turnover:521.30K
Market Cap:180.14M
PE:-13.99
High:1.03
Open:1.01
Low:0.9200
Close:1.02
Loading ...
Apr 18, 2025

Major Issues Report

Form 8-K - Current report
Apr 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2025

Major Issues Report

Form 8-K - Current report
Nov 19, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 23, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 01, 2024

Correspondence

Form CORRESP - Correspondence
Jul 31, 2024

Correspondence

Form CORRESP - Correspondence
Jul 29, 2024

Correspondence

Form CORRESP - Correspondence
Jul 23, 2024

Correspondence

Form CORRESP - Correspondence
Jul 23, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jun 22, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 22, 2024

Major Issues Report

Form 8-K - Current report
Jun 11, 2024

Major Issues Report

Form 8-K - Current report
Jun 08, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 30, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]